retatrutide clinical trial data Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials retatrutide clinical trial data done!

Dudley Lamming, a prominent researcher in the field of aging and metabolism

GLP-1 therapy also helps stabilize blood sugar levels, reducing the risk of spikes and crashes that can trigger hunger and cravings

Read more about Retartutide vs Semaglutide Retartutide VS

The trial enrolled 76 adults with type 2 diabetes and randomized them to placebo, a three-strain formula or the five-strain formula now sold as Glucose Control After 12 weeks, the group taking the five-strain probiotic saw a statistically significant improvement in post-meal blood sugar spikes and total glucose response after a test meal compared with the placebo group

Available from: 69.Rosenstock J., Wysham C., Frias J.P., et al

SeekPeptides has compiled the most comprehensive breakdown available, drawing from pharmacovigilance databases, randomized controlled trials, and systematic reviews so you can make informed decisions about your health without sacrificing your hair in the process